Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world.

Cardiovascular diseases are the No.1 cause of death globally, according to the World Health Organization. At Novartis, we focus on developing new treatment options for people living with serious cardio-metabolic diseases.

Booth Contact:

Jordan Bogen RPh
Executive Hospital Account Specialist
Cardiovascular Renal Metabolism

Contact Us Now Email Address: